Although significant progress has been made in preventing some healthcare-associated infection types, there is much more work to be done. On any given day, about one in 31 hospital patients has at least one healthcare-associated infection.
Annually, approximately 2 million patients suffer from healthcare-associated infections (HAIs) in the USA, and nearly 90,000 are estimated to die. The overall direct cost of HAIs to hospitals ranges from US $28 billion to 45 billion.
The Centers for Disease Control (CDC) has previously indicated that approximately 2,000,000 cases of hospital-acquired infections (HAIs) occur each year costing 100,000 lives. Beyond the human toll, each HAI adds approximately $15,000 to the cost of treating the patient, a $30 billion problem.
Derive Technologies provides many options to address infection control challenges. Among them are passive solutions like specialized keyboards, mice and other data-entry devices incorporating special polymers designed for long-term repetitive usage of disinfection measures such as chemical wipes. Active solutions include sterilization products utilizing UV-light-based disinfection techniques. Many solutions offer management and oversight features—helping drive best practices and protocol control into the most challenging of HAI categories.
For more information on how Derive can lend its extensive experience in infection control management to your organization, BOOK A FREE CONSULTATION for a complimentary consultation with one of our senior healthcare executives.
Derive Technologies has provided business and technological innovation for our clients through progressive, decades-long relationships with some of the world's most important providers of core infrastructure, cloud, mobility, collaboration, security and numerous other solutions.
